OTCMKTS:MAHLY MediPal (MAHLY) Stock Price, News & Analysis $18.50 0.00 (0.00%) As of 08/20/2026 10:34 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChart About MediPal Stock (OTCMKTS:MAHLY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MediPal alerts:Sign Up Key Stats Today's Range$18.50▼$18.5050-Day Range$15.37▼$18.5052-Week Range$15.37▼$20.35Volume100 shsAverage Volume658 shsMarket CapitalizationN/AP/E Ratio0.19Dividend Yield123.28%Price TargetN/AConsensus RatingN/A Company Overview MediPal (OTCMKTS: MAHLY) represents the American depositary receipts of Medipal Holdings Corporation, a Tokyo‐based integrated healthcare distributor. The company specializes in the procurement, warehousing and delivery of prescription pharmaceuticals, over-the-counter medicines, medical devices and nutritional supplements. Through its extensive logistics network, MediPal services a wide range of clients including retail pharmacies, drugstores, hospitals and clinics across Japan. In addition to its core distribution activities, MediPal offers ancillary services such as in-store pharmacy management support, inventory control systems and consulting for healthcare retailers. The company’s Retail & Consumer Business segment provides consumer health products and lifestyle goods under private-label and third-party brands. MediPal’s Hospital Business unit supplies medical equipment, surgical disposables and diagnostics to healthcare institutions, while its Pharma Solutions branch manages contract logistics and regulatory compliance services for pharmaceutical manufacturers. Beyond its domestic operations, MediPal has established a presence in key Asian markets through subsidiaries and joint ventures, facilitating cross-border procurement and distribution partnerships. Headquartered in Tokyo, the company is governed by a board of directors with deep expertise in pharmaceuticals, logistics and healthcare services. Its ADRs trade on the OTC Markets under the symbol MAHLY, providing international investors access to one of Japan’s leading healthcare distribution platforms.AI Generated. May Contain Errors. Read More Receive MAHLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MediPal and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MAHLY Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com MAHLY Stock Analysis - Frequently Asked Questions How have MAHLY shares performed this year? MediPal's stock was trading at $17.90 at the beginning of 2026. Since then, MAHLY stock has increased by 3.4% and is now trading at $18.50. How do I buy shares of MediPal? Shares of MAHLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryN/A Current SymbolOTCMKTS:MAHLY CIKN/A Webwww.medipal.co.jp Phone81-3-3517-5800FaxN/AEmployees12,795Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio0.19 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (OTCMKTS:MAHLY) was last updated on 8/22/2026 by MarketBeat.com Staff. From Our PartnersThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredYour Free Report (Inside)A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | Sponsored23,281 stocks. Only ONE survived.One American energy producer just cleared a screen of 23281 stocks for elite operating profits, double-digit r...Monument Traders Alliance | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredThe world's #2 gold miner is running on fumes [it has to buy]Barrick, the world's second-largest gold miner, produced 7.77 million ounces in 2010. This year, output is exp...Golden Portfolio | SponsoredSomeone just dumped the biggest gold fund.Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPal Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPal With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.